PharmaCyte Biotech, Inc. (PMCB) › Weighted Average Diluted SharesPharmaCyte Biotech, Inc. (PMCB) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2013-04-30: 440.95M2014-04-30: 583.22M2015-04-30: 704.33M2016-04-30: 752.40M2017-04-30: 845.31M2018-04-30: 968.64M2019-04-30: 1.10B2020-04-30: 903.8K2021-04-30: 1.45M2022-04-30: 15.52M2023-04-30: 19.49M2024-04-30: 9.58M2025-04-30: 7.33M2026-04-30: 8.38M8.38M2013-04-30Weighted Average Diluted Shares (shares)2026-04-30Period endedWeighted Average Diluted SharesChange YoYSource filing2026-04-308.38M+14.3%2026-07-29From 2025-05-012025-04-307.33M-23.5%2026-07-29From 2024-05-012024-04-309.58M-50.8%2025-08-11From 2023-05-012023-04-3019.49M+25.6%2024-08-13From 2022-05-012022-04-3015.52M+971.7%2023-07-31From 2021-05-012021-04-301.45M+60.2%2022-07-28From 2020-05-012020-04-30903.8K-99.9%2021-08-10From 2019-05-012019-04-301.10B+13.6%2020-08-13From 2018-05-012018-04-30968.64M+14.6%2019-08-13From 2017-05-012017-04-30845.31M+12.3%2018-07-20From 2016-05-012016-04-30752.40M+6.8%2017-07-27From 2015-05-012015-04-30704.33M+20.8%2016-07-29From 2014-05-012014-04-30583.22M+32.3%2016-07-29From 2013-05-012013-04-30440.95M—2016-01-19From 2012-05-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)